Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profilin Isoforms in Health and Disease - All the Same but Different. | Front Cell Dev Biol | 2021 | 34458253 | PubTator, text mining | PubMed |
| Fluorescence Correlation Spectroscopy Reveals Survival Motor Neuron Oligomerization but No Active Transport in Motor Axons of a Zebrafish Model for Spinal Muscular Atrophy. | Front Cell Dev Biol | 2021 | 34458251 | PubTator, text mining | PubMed |
| Novel Modification of a Confirmatory SMA Sequencing Assay that Can Be Used to Determine SMN2 Copy Number. | Int J Neonatal Screen | 2021 | 34449530 | PubTator, text mining | PubMed |
| Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs. | Int J Neonatal Screen | 2021 | 34449526 | PubTator, text mining | PubMed |
| The Importance of Digging into the Genetics of SMN Genes in the Therapeutic Scenario of Spinal Muscular Atrophy. | Int J Mol Sci | 2021 | 34445733 | PubTator, text mining | PubMed |
| Drug Discovery of Spinal Muscular Atrophy (SMA) from the Computational Perspective: A Comprehensive Review. | Int J Mol Sci | 2021 | 34445667 | PubTator, text mining | PubMed |
| What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective. | Int J Mol Sci | 2021 | 34445199 | PubTator, text mining | PubMed |
| High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome. | Int J Mol Sci | 2021 | 34445083 | PubTator, text mining | PubMed |
| Polyphenols and Their Effects on Muscle Atrophy and Muscle Health. | Molecules | 2021 | 34443483 | PubTator, text mining | PubMed |
| Molecular Pathology of ALS: What We Currently Know and What Important Information Is Still Missing. | Diagnostics (Basel) | 2021 | 34441299 | PubTator, text mining | PubMed |
| Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New. | Biomolecules | 2021 | 34439911 | PubTator, text mining | PubMed |
| How Inflammation Pathways Contribute to Cell Death in Neuro-Muscular Disorders. | Biomolecules | 2021 | 34439778 | PubTator, text mining | PubMed |
| Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan. | Children (Basel) | 2021 | 34438585 | PubTator, text mining | PubMed |
| Bone mineral density and its influencing factors in Chinese children with spinal muscular atrophy types 2 and 3. | BMC Musculoskelet Disord | 2021 | 34429096 | PubTator, text mining | PubMed |
| Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic ∆7SMA mice. | Neurobiol Dis | 2021 | 34425216 | PubTator, text mining | PubMed |
| Update on Biomarkers in Spinal Muscular Atrophy. | Biomark Insights | 2021 | 34421296 | PubTator, text mining | PubMed |
| Antisense Oligonucleotide Therapy for Neurodevelopmental Disorders. | Dev Neurosci | 2021 | 34412058 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid and Clinical Profiles in Adult Type 2-3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience. | Clin Drug Investig | 2021 | 34389971 | PubTator, text mining | PubMed |
| Gene therapy for spinal muscular atrophy: the benefit-cost profile. | EClinicalMedicine | 2021 | 34386755 | PubTator, text mining | PubMed |
| Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy. | Drug Saf | 2021 | 34383289 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=60